Nanotechnology and Drug Delivery, Volume Two

Nano-Engineering Strategies and Nanomedicines Against Severe Diseases
Herausgeber: Arias, Jose L

• Gebundenes Buch

Produktbeschreibung

Volume one of this book series, Nanoplatforms in Drug Delivery, established the basic aspects in the development of drug-loaded nanoplatforms, the so-called nanomedicines or nanodrugs, focusing on representative materials and strategies used in their formulation. Taking advantage of the advanced conceptualizations on nanomedicine engineering that were described in volume one, volume two, Nano-Engineering Strategies and Nanomedicines against Severe Diseases, analyzes in depth special features related to the formulation of nanoplatforms for oral, dental, topical and transdermal, pulmonary and nasal, ocular and otic, vaginal, and brain drug delivery and targeting.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: CRC Press
• Seitenzahl: 488
• Erscheinungstermin: 20. Februar 2016
• Englisch
• Abmessung: 234mm x 157mm x 33mm
• Gewicht: 1089g
• ISBN-13: 9781482262711
• ISBN-10: 1482262711
• Artikelnr.: 41026519

Autorenporträt

Jose L. Arias

Inhaltsangabe

Preface to the Book Series. Preface to Volume 2. Emerging Technologies of
Polymers for Nanomedicine Applications. Nanotechnology for Oral Drug
Delivery and Targeting. Nanoparticulate Systems for Dental Drug Delivery.
Nanotechnology for Topical and Transdermal Drug Delivery and Targeting.
Nanotechnology for Pulmonary and Nasal Drug Delivery. Lipid Nanoplatforms
for Pulmonary Drug Delivery. Nanotechnology for Ocular and Otic Drug
Delivery and Targeting. Nanotechnology for Vaginal Drug Delivery and
Targeting. Potential Nanocarriers for Brain Drug Delivery. Nanomaterials
and Cancer Therapy. Nanomedicine in Cardiovascular Disease.
Nano(Neuro)Medicinal Interventions for Neurodegenerative Disorders: a
Meta-Analysis of Concurrent Challenges and Strategic Solutions.
Nanomedicines against Infectious Diseases. Nanomedicines against Chronic
Inflammatory Diseases. Nanomedicine Biopharmaceuticals for Metabolic
Diseases. Nanotechnology in Gene Knockdown and miRNA Replacement in Vivo.
Nanotheranostics.